%0 Journal Article
%T Dectin-1-activated dendritic cells: A potent Th9 cell inducer for tumor immunotherapy
%A Jintong Chen
%A Qing Yi
%A Siqing Wang
%A Xiao Chu
%A Yinghua Zhao
%A Yong Lu
%J Archive of "Oncoimmunology".
%D 2016
%R 10.1080/2162402X.2016.1238558
%X Dendritic cell (DC)-based immunotherapy has great promise for cancer treatment. We have recently demonstrated that dectin-1-activated DCs trigger potent antitumor Th9 cells in vivo. Dectin-1-activated DC-induced antitumor responses rely on the induced Th9/IL-9. These findings offer new strategies for the development of more effective DC vaccines in tumor immunotherapy
%K Antitumor immunity
%K Dectin-1
%K dentritic cells
%K Th9
%K Vaccine
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5139651/